Phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis

Heart failure (HF) is a serious and advanced stage of various cardiac diseases with high mortality and rehospitalization rates. Phosphoglycerate mutase 2 (PGAM2) overexpression was identified in the serum of patients with HF.

Guardado en:

Detalles Bibliográficos
Autores principales:	Li Min, Gao Xiaoyuan, Wang Huiyun, Zhang Mingli, Li Xiaoying, Wang Shuya, Wang Shaoqin, Cao Chongfeng, Li Ying, Su Guohai
Formato:	article
Lenguaje:	EN
Publicado:	De Gruyter 2021
Materias:	hf biomarker pgam2 nyha cardiac function grading Medicine R
Acceso en línea:	https://doaj.org/article/29461ea7ccd74bef9469d19c10243361
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:29461ea7ccd74bef9469d19c10243361
record_format	dspace
spelling	oai:doaj.org-article:29461ea7ccd74bef9469d19c102433612021-12-05T14:10:55ZPhosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis2391-546310.1515/med-2021-0324https://doaj.org/article/29461ea7ccd74bef9469d19c102433612021-08-01T00:00:00Zhttps://doi.org/10.1515/med-2021-0324https://doaj.org/toc/2391-5463Heart failure (HF) is a serious and advanced stage of various cardiac diseases with high mortality and rehospitalization rates. Phosphoglycerate mutase 2 (PGAM2) overexpression was identified in the serum of patients with HF.Li MinGao XiaoyuanWang HuiyunZhang MingliLi XiaoyingWang ShuyaWang ShaoqinCao ChongfengLi YingSu GuohaiDe Gruyterarticlehfbiomarkerpgam2nyhacardiac function gradingMedicineRENOpen Medicine, Vol 16, Iss 1, Pp 1134-1142 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	hf biomarker pgam2 nyha cardiac function grading Medicine R
spellingShingle	hf biomarker pgam2 nyha cardiac function grading Medicine R Li Min Gao Xiaoyuan Wang Huiyun Zhang Mingli Li Xiaoying Wang Shuya Wang Shaoqin Cao Chongfeng Li Ying Su Guohai Phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis
description	Heart failure (HF) is a serious and advanced stage of various cardiac diseases with high mortality and rehospitalization rates. Phosphoglycerate mutase 2 (PGAM2) overexpression was identified in the serum of patients with HF.
format	article
author	Li Min Gao Xiaoyuan Wang Huiyun Zhang Mingli Li Xiaoying Wang Shuya Wang Shaoqin Cao Chongfeng Li Ying Su Guohai
author_facet	Li Min Gao Xiaoyuan Wang Huiyun Zhang Mingli Li Xiaoying Wang Shuya Wang Shaoqin Cao Chongfeng Li Ying Su Guohai
author_sort	Li Min
title	Phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis
title_short	Phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis
title_full	Phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis
title_fullStr	Phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis
title_full_unstemmed	Phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis
title_sort	phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis
publisher	De Gruyter
publishDate	2021
url	https://doaj.org/article/29461ea7ccd74bef9469d19c10243361
work_keys_str_mv	AT limin phosphoglyceratemutase2iselevatedinserumofpatientswithheartfailureandcorrelateswiththediseaseseverityandpatientsprognosis AT gaoxiaoyuan phosphoglyceratemutase2iselevatedinserumofpatientswithheartfailureandcorrelateswiththediseaseseverityandpatientsprognosis AT wanghuiyun phosphoglyceratemutase2iselevatedinserumofpatientswithheartfailureandcorrelateswiththediseaseseverityandpatientsprognosis AT zhangmingli phosphoglyceratemutase2iselevatedinserumofpatientswithheartfailureandcorrelateswiththediseaseseverityandpatientsprognosis AT lixiaoying phosphoglyceratemutase2iselevatedinserumofpatientswithheartfailureandcorrelateswiththediseaseseverityandpatientsprognosis AT wangshuya phosphoglyceratemutase2iselevatedinserumofpatientswithheartfailureandcorrelateswiththediseaseseverityandpatientsprognosis AT wangshaoqin phosphoglyceratemutase2iselevatedinserumofpatientswithheartfailureandcorrelateswiththediseaseseverityandpatientsprognosis AT caochongfeng phosphoglyceratemutase2iselevatedinserumofpatientswithheartfailureandcorrelateswiththediseaseseverityandpatientsprognosis AT liying phosphoglyceratemutase2iselevatedinserumofpatientswithheartfailureandcorrelateswiththediseaseseverityandpatientsprognosis AT suguohai phosphoglyceratemutase2iselevatedinserumofpatientswithheartfailureandcorrelateswiththediseaseseverityandpatientsprognosis
_version_	1718371591821197312

Phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis

Ejemplares similares